Brad hauser, ceo of autonomix medical, inc. outlines follow-on expansion study expected to begin in q2 2025, potentially doubling addressable market

Discussion in virtual investor ceo connect focuses on company's planned follow-on market expansion study phase (“poc 2”) of proof-of-concept trial; access here

AMIX Ratings Summary

AMIX Quant Ranking